Article Details
Retrieved on: 2022-01-06 13:29:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe. It is intended for ...
Article found on: valneva.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here